Significant change:Updated indication with the addition of Mycoplasma bovis and associated warnings and precautions.
For therapeutic treatment of bovine respiratory disease (BRD) due to Histophilus
somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma bovis
associated with pyrexia.